Jens O. Schmid
Impact in
-
- Cancer Cells and Metastasis
-
- Cancer, Hypoxia, and Metabolism
Papers in
- Oncology 5
- Cancer Cells and Metastasis 3
- HER2/EGFR in Cancer Research 2
- PARP inhibition in cancer therapy 1
-
- RNA Interference and Gene Delivery 2
- Peroxisome Proliferator-Activated Receptors 1
- Co-authors
- Thomas E. Mürdter (6 shared papers)Heiko van der Kuip (4 shared papers)Walter E. Aulitzky (4 shared papers)Godehard Friedel (3 shared papers)Maike Sonnenberg (2 shared papers)Matthias Schwab (2 shared papers)Christoph Ulmer (1 shared paper)Georg Sauer (1 shared paper)
- Journals
- Cancer Research (2 papers)JACC Basic to Translational Science (1 paper)Hereditas (1 paper)Oncotarget (1 paper)Cell Death and Differentiation (1 paper)
- Partner nations
- GermanySwitzerlandIreland
In The Last Decade
Jens O. Schmid
9 papers receiving 285 citations
Peers
Comparison fields: 5 of 52
- Oncology 88
- Cancer Research 30
- Cardiology and Cardiovascular Medicine 39
- Immunology 39
- Cell Biology 29
Countries citing papers authored by Jens O. Schmid
This map shows the geographic impact of Jens O. Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens O. Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens O. Schmid more than expected).
Fields of papers citing papers by Jens O. Schmid
This network shows the impact of papers produced by Jens O. Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens O. Schmid. The network helps show where Jens O. Schmid may publish in the future.
Co-authors
The 25 scholars most cited alongside Jens O. Schmid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 66 | |
| 2 | 2017 | 64 | |
| 3 | 2016 | 61 | |
| 4 | 2021 | 27 | |
| 5 | 2012 | 25 | |
| 6 | 2020 | 20 | |
| 7 | 2016 | 11 | |
| 8 | 2010 | 10 | |
| 9 | Short communication Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts | 2010 | 2 |
About Jens O. Schmid
Jens O. Schmid is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Hematology, having authored 9 papers that have together received 286 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), HER2/EGFR in Cancer Research (2 papers), RNA Interference and Gene Delivery (2 papers), Lung Cancer Treatments and Mutations (2 papers), Cardiac Valve Diseases and Treatments (2 papers), Peroxisome Proliferator-Activated Receptors (1 paper) and PARP inhibition in cancer therapy (1 paper). The work is most often cited by research in Oncology (88 citations), Cancer Research (30 citations), Cardiology and Cardiovascular Medicine (39 citations), Immunology (39 citations) and Cell Biology (29 citations). Jens O. Schmid has collaborated with scholars based in Germany, Switzerland and Ireland. Frequent co-authors include Thomas E. Mürdter, Heiko van der Kuip, Walter E. Aulitzky, Godehard Friedel, Maike Sonnenberg, Matthias Schwab, Christoph Ulmer, Georg Sauer, Michael Torzewski and Simon Heine. Their work appears in journals such as Cancer Research, JACC Basic to Translational Science, Hereditas, Oncotarget and Cell Death and Differentiation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.